0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dihydrocodeine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-23A7994
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dihydrocodeine Market Insights Forecast to 2028
BUY CHAPTERS

Dihydrocodeine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23A7994
Report
November 2024
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dihydrocodeine - Market Size

The global market for Dihydrocodeine was estimated to be worth US$ 2533 million in 2023 and is forecast to a readjusted size of US$ 3558 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Dihydrocodeine - Market

Dihydrocodeine - Market

Dihydrocodeine is a semi-synthetic opioid analgesic prescribed for pain or severe dyspnea, or as an antitussive, either alone or compounded with paracetamol (acetaminophen) (as in co-dydramol) or aspirin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dihydrocodeine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dihydrocodeine by region & country, by Type, and by Application.
The Dihydrocodeine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydrocodeine.
Market Segmentation

Scope of Dihydrocodeine - Market Report

Report Metric Details
Report Name Dihydrocodeine - Market
Forecasted market size in 2030 US$ 3558 million
CAGR 5.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Oral
  • Injection
Segment by Application
  • Cough Suppressant
  • Analgesic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AHPL, Teofarma, Mundipharma, Napp Pharmaceuticals, Aspen Pharmacare, Martindale-Hubbell, Duopharma Biotech Berhad, Wockhardt, Auden Mckenzie Pharma, WraSer, GlaxoSmithKline, G.L. Pharma, Daiichi Sankyo, Fuso Pharmaceutical, Nichi-Iko Pharmaceutical, Takata Pharmaceutical, Toyo Seikan Group, Teva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Dihydrocodeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Dihydrocodeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Dihydrocodeine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Dihydrocodeine - Market size in 2030?

Ans: The Dihydrocodeine - Market size in 2030 will be US$ 3558 million.

Who are the main players in the Dihydrocodeine - Market report?

Ans: The main players in the Dihydrocodeine - Market are AHPL, Teofarma, Mundipharma, Napp Pharmaceuticals, Aspen Pharmacare, Martindale-Hubbell, Duopharma Biotech Berhad, Wockhardt, Auden Mckenzie Pharma, WraSer, GlaxoSmithKline, G.L. Pharma, Daiichi Sankyo, Fuso Pharmaceutical, Nichi-Iko Pharmaceutical, Takata Pharmaceutical, Toyo Seikan Group, Teva

What are the Application segmentation covered in the Dihydrocodeine - Market report?

Ans: The Applications covered in the Dihydrocodeine - Market report are Cough Suppressant, Analgesic

What are the Type segmentation covered in the Dihydrocodeine - Market report?

Ans: The Types covered in the Dihydrocodeine - Market report are Oral, Injection

1 Market Overview
1.1 Dihydrocodeine Product Introduction
1.2 Global Dihydrocodeine Market Size Forecast
1.2.1 Global Dihydrocodeine Sales Value (2019-2030)
1.2.2 Global Dihydrocodeine Sales Volume (2019-2030)
1.2.3 Global Dihydrocodeine Sales Price (2019-2030)
1.3 Dihydrocodeine Market Trends & Drivers
1.3.1 Dihydrocodeine Industry Trends
1.3.2 Dihydrocodeine Market Drivers & Opportunity
1.3.3 Dihydrocodeine Market Challenges
1.3.4 Dihydrocodeine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dihydrocodeine Players Revenue Ranking (2023)
2.2 Global Dihydrocodeine Revenue by Company (2019-2024)
2.3 Global Dihydrocodeine Players Sales Volume Ranking (2023)
2.4 Global Dihydrocodeine Sales Volume by Company Players (2019-2024)
2.5 Global Dihydrocodeine Average Price by Company (2019-2024)
2.6 Key Manufacturers Dihydrocodeine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dihydrocodeine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dihydrocodeine
2.9 Dihydrocodeine Market Competitive Analysis
2.9.1 Dihydrocodeine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dihydrocodeine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydrocodeine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Injection
3.2 Global Dihydrocodeine Sales Value by Type
3.2.1 Global Dihydrocodeine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dihydrocodeine Sales Value, by Type (2019-2030)
3.2.3 Global Dihydrocodeine Sales Value, by Type (%) (2019-2030)
3.3 Global Dihydrocodeine Sales Volume by Type
3.3.1 Global Dihydrocodeine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dihydrocodeine Sales Volume, by Type (2019-2030)
3.3.3 Global Dihydrocodeine Sales Volume, by Type (%) (2019-2030)
3.4 Global Dihydrocodeine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cough Suppressant
4.1.2 Analgesic
4.2 Global Dihydrocodeine Sales Value by Application
4.2.1 Global Dihydrocodeine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dihydrocodeine Sales Value, by Application (2019-2030)
4.2.3 Global Dihydrocodeine Sales Value, by Application (%) (2019-2030)
4.3 Global Dihydrocodeine Sales Volume by Application
4.3.1 Global Dihydrocodeine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dihydrocodeine Sales Volume, by Application (2019-2030)
4.3.3 Global Dihydrocodeine Sales Volume, by Application (%) (2019-2030)
4.4 Global Dihydrocodeine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dihydrocodeine Sales Value by Region
5.1.1 Global Dihydrocodeine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dihydrocodeine Sales Value by Region (2019-2024)
5.1.3 Global Dihydrocodeine Sales Value by Region (2025-2030)
5.1.4 Global Dihydrocodeine Sales Value by Region (%), (2019-2030)
5.2 Global Dihydrocodeine Sales Volume by Region
5.2.1 Global Dihydrocodeine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dihydrocodeine Sales Volume by Region (2019-2024)
5.2.3 Global Dihydrocodeine Sales Volume by Region (2025-2030)
5.2.4 Global Dihydrocodeine Sales Volume by Region (%), (2019-2030)
5.3 Global Dihydrocodeine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dihydrocodeine Sales Value, 2019-2030
5.4.2 North America Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dihydrocodeine Sales Value, 2019-2030
5.5.2 Europe Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dihydrocodeine Sales Value, 2019-2030
5.6.2 Asia Pacific Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dihydrocodeine Sales Value, 2019-2030
5.7.2 South America Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dihydrocodeine Sales Value, 2019-2030
5.8.2 Middle East & Africa Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dihydrocodeine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dihydrocodeine Sales Value
6.2.1 Key Countries/Regions Dihydrocodeine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dihydrocodeine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dihydrocodeine Sales Value, 2019-2030
6.3.2 United States Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dihydrocodeine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dihydrocodeine Sales Value, 2019-2030
6.4.2 Europe Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dihydrocodeine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dihydrocodeine Sales Value, 2019-2030
6.5.2 China Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dihydrocodeine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dihydrocodeine Sales Value, 2019-2030
6.6.2 Japan Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dihydrocodeine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dihydrocodeine Sales Value, 2019-2030
6.7.2 South Korea Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dihydrocodeine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dihydrocodeine Sales Value, 2019-2030
6.8.2 Southeast Asia Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dihydrocodeine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dihydrocodeine Sales Value, 2019-2030
6.9.2 India Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dihydrocodeine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 AHPL
7.1.1 AHPL Company Information
7.1.2 AHPL Introduction and Business Overview
7.1.3 AHPL Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 AHPL Dihydrocodeine Product Offerings
7.1.5 AHPL Recent Development
7.2 Teofarma
7.2.1 Teofarma Company Information
7.2.2 Teofarma Introduction and Business Overview
7.2.3 Teofarma Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Teofarma Dihydrocodeine Product Offerings
7.2.5 Teofarma Recent Development
7.3 Mundipharma
7.3.1 Mundipharma Company Information
7.3.2 Mundipharma Introduction and Business Overview
7.3.3 Mundipharma Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Mundipharma Dihydrocodeine Product Offerings
7.3.5 Mundipharma Recent Development
7.4 Napp Pharmaceuticals
7.4.1 Napp Pharmaceuticals Company Information
7.4.2 Napp Pharmaceuticals Introduction and Business Overview
7.4.3 Napp Pharmaceuticals Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Napp Pharmaceuticals Dihydrocodeine Product Offerings
7.4.5 Napp Pharmaceuticals Recent Development
7.5 Aspen Pharmacare
7.5.1 Aspen Pharmacare Company Information
7.5.2 Aspen Pharmacare Introduction and Business Overview
7.5.3 Aspen Pharmacare Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Aspen Pharmacare Dihydrocodeine Product Offerings
7.5.5 Aspen Pharmacare Recent Development
7.6 Martindale-Hubbell
7.6.1 Martindale-Hubbell Company Information
7.6.2 Martindale-Hubbell Introduction and Business Overview
7.6.3 Martindale-Hubbell Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Martindale-Hubbell Dihydrocodeine Product Offerings
7.6.5 Martindale-Hubbell Recent Development
7.7 Duopharma Biotech Berhad
7.7.1 Duopharma Biotech Berhad Company Information
7.7.2 Duopharma Biotech Berhad Introduction and Business Overview
7.7.3 Duopharma Biotech Berhad Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Duopharma Biotech Berhad Dihydrocodeine Product Offerings
7.7.5 Duopharma Biotech Berhad Recent Development
7.8 Wockhardt
7.8.1 Wockhardt Company Information
7.8.2 Wockhardt Introduction and Business Overview
7.8.3 Wockhardt Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Wockhardt Dihydrocodeine Product Offerings
7.8.5 Wockhardt Recent Development
7.9 Auden Mckenzie Pharma
7.9.1 Auden Mckenzie Pharma Company Information
7.9.2 Auden Mckenzie Pharma Introduction and Business Overview
7.9.3 Auden Mckenzie Pharma Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Auden Mckenzie Pharma Dihydrocodeine Product Offerings
7.9.5 Auden Mckenzie Pharma Recent Development
7.10 WraSer
7.10.1 WraSer Company Information
7.10.2 WraSer Introduction and Business Overview
7.10.3 WraSer Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WraSer Dihydrocodeine Product Offerings
7.10.5 WraSer Recent Development
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Information
7.11.2 GlaxoSmithKline Introduction and Business Overview
7.11.3 GlaxoSmithKline Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 GlaxoSmithKline Dihydrocodeine Product Offerings
7.11.5 GlaxoSmithKline Recent Development
7.12 G.L. Pharma
7.12.1 G.L. Pharma Company Information
7.12.2 G.L. Pharma Introduction and Business Overview
7.12.3 G.L. Pharma Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 G.L. Pharma Dihydrocodeine Product Offerings
7.12.5 G.L. Pharma Recent Development
7.13 Daiichi Sankyo
7.13.1 Daiichi Sankyo Company Information
7.13.2 Daiichi Sankyo Introduction and Business Overview
7.13.3 Daiichi Sankyo Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Daiichi Sankyo Dihydrocodeine Product Offerings
7.13.5 Daiichi Sankyo Recent Development
7.14 Fuso Pharmaceutical
7.14.1 Fuso Pharmaceutical Company Information
7.14.2 Fuso Pharmaceutical Introduction and Business Overview
7.14.3 Fuso Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Fuso Pharmaceutical Dihydrocodeine Product Offerings
7.14.5 Fuso Pharmaceutical Recent Development
7.15 Nichi-Iko Pharmaceutical
7.15.1 Nichi-Iko Pharmaceutical Company Information
7.15.2 Nichi-Iko Pharmaceutical Introduction and Business Overview
7.15.3 Nichi-Iko Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Nichi-Iko Pharmaceutical Dihydrocodeine Product Offerings
7.15.5 Nichi-Iko Pharmaceutical Recent Development
7.16 Takata Pharmaceutical
7.16.1 Takata Pharmaceutical Company Information
7.16.2 Takata Pharmaceutical Introduction and Business Overview
7.16.3 Takata Pharmaceutical Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Takata Pharmaceutical Dihydrocodeine Product Offerings
7.16.5 Takata Pharmaceutical Recent Development
7.17 Toyo Seikan Group
7.17.1 Toyo Seikan Group Company Information
7.17.2 Toyo Seikan Group Introduction and Business Overview
7.17.3 Toyo Seikan Group Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Toyo Seikan Group Dihydrocodeine Product Offerings
7.17.5 Toyo Seikan Group Recent Development
7.18 Teva
7.18.1 Teva Company Information
7.18.2 Teva Introduction and Business Overview
7.18.3 Teva Dihydrocodeine Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Teva Dihydrocodeine Product Offerings
7.18.5 Teva Recent Development
8 Industry Chain Analysis
8.1 Dihydrocodeine Industrial Chain
8.2 Dihydrocodeine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dihydrocodeine Sales Model
8.5.2 Sales Channel
8.5.3 Dihydrocodeine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dihydrocodeine Market Trends
    Table 2. Dihydrocodeine Market Drivers & Opportunity
    Table 3. Dihydrocodeine Market Challenges
    Table 4. Dihydrocodeine Market Restraints
    Table 5. Global Dihydrocodeine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dihydrocodeine Revenue Market Share by Company (2019-2024)
    Table 7. Global Dihydrocodeine Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Dihydrocodeine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Dihydrocodeine Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Dihydrocodeine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Dihydrocodeine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Dihydrocodeine
    Table 13. Global Dihydrocodeine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydrocodeine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dihydrocodeine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Dihydrocodeine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Dihydrocodeine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Dihydrocodeine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Dihydrocodeine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Dihydrocodeine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Dihydrocodeine Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Dihydrocodeine Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Dihydrocodeine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Dihydrocodeine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Dihydrocodeine Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Dihydrocodeine Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Dihydrocodeine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Dihydrocodeine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Dihydrocodeine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Dihydrocodeine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Dihydrocodeine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Dihydrocodeine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Dihydrocodeine Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Dihydrocodeine Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Dihydrocodeine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Dihydrocodeine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Dihydrocodeine Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Dihydrocodeine Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Dihydrocodeine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Dihydrocodeine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Dihydrocodeine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Dihydrocodeine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Dihydrocodeine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Dihydrocodeine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Dihydrocodeine Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Dihydrocodeine Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Dihydrocodeine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Dihydrocodeine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Dihydrocodeine Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Dihydrocodeine Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Dihydrocodeine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Dihydrocodeine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Dihydrocodeine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Dihydrocodeine Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Dihydrocodeine Sales Volume, (2025-2030) & (K Units)
    Table 57. AHPL Company Information
    Table 58. AHPL Introduction and Business Overview
    Table 59. AHPL Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. AHPL Dihydrocodeine Product Offerings
    Table 61. AHPL Recent Development
    Table 62. Teofarma Company Information
    Table 63. Teofarma Introduction and Business Overview
    Table 64. Teofarma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Teofarma Dihydrocodeine Product Offerings
    Table 66. Teofarma Recent Development
    Table 67. Mundipharma Company Information
    Table 68. Mundipharma Introduction and Business Overview
    Table 69. Mundipharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Mundipharma Dihydrocodeine Product Offerings
    Table 71. Mundipharma Recent Development
    Table 72. Napp Pharmaceuticals Company Information
    Table 73. Napp Pharmaceuticals Introduction and Business Overview
    Table 74. Napp Pharmaceuticals Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Napp Pharmaceuticals Dihydrocodeine Product Offerings
    Table 76. Napp Pharmaceuticals Recent Development
    Table 77. Aspen Pharmacare Company Information
    Table 78. Aspen Pharmacare Introduction and Business Overview
    Table 79. Aspen Pharmacare Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Aspen Pharmacare Dihydrocodeine Product Offerings
    Table 81. Aspen Pharmacare Recent Development
    Table 82. Martindale-Hubbell Company Information
    Table 83. Martindale-Hubbell Introduction and Business Overview
    Table 84. Martindale-Hubbell Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Martindale-Hubbell Dihydrocodeine Product Offerings
    Table 86. Martindale-Hubbell Recent Development
    Table 87. Duopharma Biotech Berhad Company Information
    Table 88. Duopharma Biotech Berhad Introduction and Business Overview
    Table 89. Duopharma Biotech Berhad Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Duopharma Biotech Berhad Dihydrocodeine Product Offerings
    Table 91. Duopharma Biotech Berhad Recent Development
    Table 92. Wockhardt Company Information
    Table 93. Wockhardt Introduction and Business Overview
    Table 94. Wockhardt Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Wockhardt Dihydrocodeine Product Offerings
    Table 96. Wockhardt Recent Development
    Table 97. Auden Mckenzie Pharma Company Information
    Table 98. Auden Mckenzie Pharma Introduction and Business Overview
    Table 99. Auden Mckenzie Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Auden Mckenzie Pharma Dihydrocodeine Product Offerings
    Table 101. Auden Mckenzie Pharma Recent Development
    Table 102. WraSer Company Information
    Table 103. WraSer Introduction and Business Overview
    Table 104. WraSer Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. WraSer Dihydrocodeine Product Offerings
    Table 106. WraSer Recent Development
    Table 107. GlaxoSmithKline Company Information
    Table 108. GlaxoSmithKline Introduction and Business Overview
    Table 109. GlaxoSmithKline Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. GlaxoSmithKline Dihydrocodeine Product Offerings
    Table 111. GlaxoSmithKline Recent Development
    Table 112. G.L. Pharma Company Information
    Table 113. G.L. Pharma Introduction and Business Overview
    Table 114. G.L. Pharma Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. G.L. Pharma Dihydrocodeine Product Offerings
    Table 116. G.L. Pharma Recent Development
    Table 117. Daiichi Sankyo Company Information
    Table 118. Daiichi Sankyo Introduction and Business Overview
    Table 119. Daiichi Sankyo Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Daiichi Sankyo Dihydrocodeine Product Offerings
    Table 121. Daiichi Sankyo Recent Development
    Table 122. Fuso Pharmaceutical Company Information
    Table 123. Fuso Pharmaceutical Introduction and Business Overview
    Table 124. Fuso Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Fuso Pharmaceutical Dihydrocodeine Product Offerings
    Table 126. Fuso Pharmaceutical Recent Development
    Table 127. Nichi-Iko Pharmaceutical Company Information
    Table 128. Nichi-Iko Pharmaceutical Introduction and Business Overview
    Table 129. Nichi-Iko Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Nichi-Iko Pharmaceutical Dihydrocodeine Product Offerings
    Table 131. Nichi-Iko Pharmaceutical Recent Development
    Table 132. Takata Pharmaceutical Company Information
    Table 133. Takata Pharmaceutical Introduction and Business Overview
    Table 134. Takata Pharmaceutical Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Takata Pharmaceutical Dihydrocodeine Product Offerings
    Table 136. Takata Pharmaceutical Recent Development
    Table 137. Toyo Seikan Group Company Information
    Table 138. Toyo Seikan Group Introduction and Business Overview
    Table 139. Toyo Seikan Group Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Toyo Seikan Group Dihydrocodeine Product Offerings
    Table 141. Toyo Seikan Group Recent Development
    Table 142. Teva Company Information
    Table 143. Teva Introduction and Business Overview
    Table 144. Teva Dihydrocodeine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Teva Dihydrocodeine Product Offerings
    Table 146. Teva Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Dihydrocodeine Downstream Customers
    Table 150. Dihydrocodeine Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dihydrocodeine Product Picture
    Figure 2. Global Dihydrocodeine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dihydrocodeine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Dihydrocodeine Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Dihydrocodeine Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Dihydrocodeine Report Years Considered
    Figure 7. Global Dihydrocodeine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Dihydrocodeine Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dihydrocodeine Revenue in 2023
    Figure 10. Dihydrocodeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Picture
    Figure 12. Injection Picture
    Figure 13. Global Dihydrocodeine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Dihydrocodeine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Dihydrocodeine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Dihydrocodeine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Dihydrocodeine Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Cough Suppressant
    Figure 19. Product Picture of Analgesic
    Figure 20. Global Dihydrocodeine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Dihydrocodeine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Dihydrocodeine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Dihydrocodeine Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Dihydrocodeine Price by Application (2019-2030) & (US$/Unit)
    Figure 25. North America Dihydrocodeine Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Dihydrocodeine Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Dihydrocodeine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Dihydrocodeine Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Dihydrocodeine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Dihydrocodeine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Dihydrocodeine Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Dihydrocodeine Sales Volume (%), (2019-2030)
    Figure 37. United States Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Dihydrocodeine Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Dihydrocodeine Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Dihydrocodeine Sales Value by Application (%), 2023 VS 2030
    Figure 58. Dihydrocodeine Industrial Chain
    Figure 59. Dihydrocodeine Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS